Review of tocilizumab in the treatment of rheumatoid arthritis
Yasuaki OkudaDepartment of Internal Medicine, Center for Rheumatic Diseases, Dohgo Spa Hospital, Matsuyama-city, Ehime, JapanAbstract: Constitutively overproduced in proliferating synovial tissues, interleukin-6 (IL-6) is deeply involved in the pathology of rheumatoid arthritis (RA). Tocilizumab is...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-03-01
|
Series: | Biologics : Targets & Therapy |
Online Access: | http://www.dovepress.com/review-of-tocilizumab-in-the-treatment-of-rheumatoid-arthritis-a56 |